Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma have been highlighted in this Industry Outlook article.
| Ticker |
Sentiment |
Impact |
|
FOLD
|
Neutral
|
10 %
|
|
VRNA
|
Somewhat Bullish
|
12 %
|
|
VRTX
|
Somewhat Bullish
|
5 %
|
|
EXEL
|
Neutral
|
15 %
|
|
BPMC
|
Neutral
|
7 %
|
|
GILD
|
Neutral
|
2 %
|
|
LBPH
|
Neutral
|
2 %
|
